WuXi PharmaTech (Cayman) Inc. Sustainability Profile
WuXi PharmaTech (Cayman) Inc., commonly referred to as WuXi AppTec, is a leading global pharmaceutical and biotechnology company headquartered in China. Founded in 2000, the company has established a strong presence in major operational regions, including North America and Europe, providing comprehensive services across the drug development lifecycle. Specialising in contract research, development, and manufacturing, WuXi AppTec offers unique solutions that streamline the process from discovery to commercialisation. Their core services encompass small molecule and biologics development, as well as advanced manufacturing capabilities, which set them apart in the competitive landscape. With a commitment to innovation and quality, WuXi AppTec has achieved significant milestones, positioning itself as a trusted partner for pharmaceutical companies worldwide. Their dedication to enhancing drug development efficiency has earned them a notable reputation in the industry.
DitchCarbon Score
How does WuXi PharmaTech (Cayman) Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
WuXi PharmaTech (Cayman) Inc.'s score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
WuXi PharmaTech (Cayman) Inc.'s reported carbon emissions
WuXi PharmaTech (Cayman) Inc., headquartered in China (CN), has not disclosed specific carbon emissions data for recent years, including Scope 1, 2, or 3 emissions. The latest available data from 2019 indicates that the company has not reported absolute emissions figures, nor has it set any reduction targets or climate pledges. As a current subsidiary, WuXi PharmaTech (Cayman) Inc. inherits its emissions data and climate commitments from its parent organisation, but no specific details are provided regarding these cascaded emissions or initiatives. The company has not outlined any significant climate commitments or reduction initiatives, which may reflect broader industry trends or challenges in reporting. In summary, while WuXi PharmaTech (Cayman) Inc. is part of a larger corporate family, it currently lacks specific emissions data and defined climate commitments, highlighting an area for potential improvement in transparency and sustainability efforts.
How Carbon Intensive is WuXi PharmaTech (Cayman) Inc.'s Industry?
How Carbon Intensive is WuXi PharmaTech (Cayman) Inc.'s Location?
WuXi PharmaTech (Cayman) Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
WuXi PharmaTech (Cayman) Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
